News Focus
News Focus
icon url

Investor082

12/30/25 11:22 AM

#805476 RE: jesster64 #805465

“Or maybe they are diluting now like a drunk monkey who was given 900 million more shares.”

—it will be interesting to compare Q1 2026 vs Q1 2025 dilution! ;) Any bet on which will be higher?
icon url

exwannabe

12/30/25 11:45 AM

#805493 RE: jesster64 #805465

with ASM being mainly positive


OK, I'll bite.

Regulatory
. MHRA still asking questions
. NICE submission had contractors working on it a year ago and now crickets
. FDA. Other RAs were a priority 2 years ago and now not going to happen until after an MHRA decision.

Trials
. Direct: Supposed to start this last year (like 2015,16,17,..._). Now officially on the shelf
. Roswell trials: inlicensed trials have been suspended (though if longs have ID'd the correct trials they have been completed/terminated with a total of 1 patient)
. Combo trials: Not the hoped for -L combo, but an early stage trial with some Roswell tech that will likely be starting 2027 or later.

Manufacturing
. Eden: Previously had a GMP design complete and now have 2 contract firms working on it. Oh, and 2 feet made it too big to fit in a cleanroom? So I guess they are not getting dozens in as longs suggest.
. Class C; A month ago supposed to be complete in Q2 2026. Now not starting until end of Jan

At least they did not show video of the man in the red hoody.